In addition, TAGAP, as a c-Rel suppressor in CD4+ T cells could promote their differentiation into Th1/Th17 cells and inhibit their differentiation into Tregs, thereby rejuvenating the anti-tumor ability of CD4+ T cells. The gene discussed is REL; the disease is neoplasm.